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A novel monoclonal antibody termed 8D6 was generated against the hu- 
man leukemic T-cell line Molt 13 and was found to recognize the neuro- 
thelin structure, recently termed CD147. UM8D6 precipitated a single 
band from HSB2 cells of molecular weight 35 kDa nonreduced and 40 kDa 
reduced. CD147 is broadly expressed on human hematopoietic cells and is 
expressed more intensely on thymocytes than on mature peripheral blood 
T cells. A clear distinction was found by three-color flow cytometry be- 
tween antigen density on single positive mature thymocytes subsets com- 
pared with the corresponding subset from peripheral blood. The SD6 
antibody did not have direct effects on T-cell activation or apoptosis, and 
the function of CD147 in development and activation of T cells is not yet 
clear. Nevertheless, its highly regulated expression during T-cell differen- 
tiation and the structural characteristics of this antigen suggest that it has 
1 an interesting and important role in T-cell biology. 
Cells of lymphoid origin and the central nervous 
system share a variety of surface markers, such as 
CD6, CD90 (Thy-1) and various adhesion mol- 
ecules. Neurothelin, a glycoprotein which is ex- 
pressed on endothelial cells, is thought to play an 
important role in the blood brain barrier (1). 
Other names for this molecule include HT7 (chick 
and mouse), OX-47 (rat), basigin (mouse), M6 (hu- 
man) and EMMPRIN ( 1 4 ) .  
Neurothelin-related determinants are also ex- 
pressed on cells of lymphoid origin. The OX-47 
antigen is found at low levels on rat lymphocytes 
and is upregulated upon activation in both T and 
B cells (2). The M6 antigen, present on peripheral 
granulocytes of patients with rheumatoid and re- 
active arthritis, is also expressed on a variety of T- 
cell, B-cell, erythroid, and myeloid cell lines (3). 
This structure has recently been designated CD147 
by the 6th International Workshop and Confer- 
ence on Human Leukocyte Differentiation Anti- 
gens (4). However, information is not yet available 
on the developmental expression of neurothelin by 
human lymphoid cells. 
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of human CD147/neurothelin as recognized by a 
new monoclonal antibody termed 8D6. CD147/ 
neurothelin is widely expressed on cells of 
hematopoietic origin and has a specific pattern of 
expression during the development of T-lineage 
cells. 
Material and methods 
Antibodies 
Production of the 806 monoclonal antibody. A sub- 
tractive immunization technique was used to de- 
velop monoclonal antibodies to less immunogenic 
antigens or epitopes on the thymocyte cell surface. 
A 6-week-old female BALB/c mouse was serially 
immunized (3 immunizations at 2-week intervals) 
with Peer cells, a human T-cell leukemic line. Each 
immunization was followed by treatment with 
cyclophosphamide, as previously described (5) .  
The same mouse was then immunized and boosted 
twice with cells from a second leukemic T-cell line, 
Molt 13. Hybridoma 8D6 (IgGI) was subcloned 
and propagated in ascites form in pristane-primed 
mice. 
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Other antibodies: 7F8 (anti-CD98) was produced 
using the method described above (5). Anti-CD3- 
tricolor, anti-CD4-phycoerythrin (PE), anti-CD8- 
PE were obtained from Caltag. Fluorescein iso- 
thionyanate-conjugated goat anti-mouse antibody 
was obtained from Coulter. OKT3 (anti-CD3) was 
produced from hybridoma cells obtained from 
ATCC, and UMCD2 (anti-CD2) was produced as 
previously described (6). Anti-AD2 (7) was a gift 
from B. Haynes and D. Pate1 of Duke University. 
Cells 
Human peripheral blood mononuclear cells were 
obtained from venous blood of healthy volunteers 
by centrifugation over Ficoll-Hypaque. Thymic 
tissue was obtained as excess surgical material 
from children who underwent corrective cardiac 
surgery. It was finely minced and pressed through 
a stainless steel mesh to prepare a single-cell sus- 
pension. Thymocytes and peripheral blood mono- 
nuclear cells were separated from red blood cells 
and debris by centrifugation over Ficoll-Hypaque 
and washed three times. 
The human T-cell leukemic lines HSB-2, Jurkat, 
Peer, Hut-78 and Molt 13 were maintained in con- 
tinuous cell culture in our laboratory. 
lrnmunoprecipitation 
Cells of the HSB-2 T cell line were metabolically 
labeled with [35]-S-methionine for 4.5 h and then 
lysed and precleared as previously described (9, 
immunoprecipitated by incubating the lysate first 
with 8D6 antibody, followed by addition of pro- 
tein-G Sepharose beads. Immunoprecipitates were 
analyzed by SDS-PAGE under reducing and non- 
reducing conditions. 
Flow cytometry analysis 
Single-color fzow cytometry. Monoclonal anti- 
bodies were used at saturating concentrations. Sur- 
face antigen expression was determined using in- 
direct or direct immunofluorescence using an Epics 
3 or Elite Cell Sorter (Coulter Electronics, Hiale- 
ah, FL, USA). Cell populations of interest were 
selected using forward and right angle light scatter 
gating. 
Three-color fzow cytometry. Thymocytes and pe- 
ripheral blood mononuclear cells obtained on the 
same day were placed into tubes (5.0X lo5 cells per 
tube) in 50 pl of phosphate-buffered saline (PBS). 
Fifty pl of antibody (8D6, 7F8 or controls) was 
added to appropriate tubes and incubated for 30 
min at 4°C. After washing twice with 2 p1 of PBS, 
5 pl of CD4-PE or CD8-PE and 50 pl of CD3-TC 
(or appropriate controls) were added and incu- 
bated for 30 min at 4°C. Cells were washed twice 
with 2 ml of PBS and resuspended in fixative 
(formaldehyde 1%). Cells were analyzed by a Coul- 
ter Elite cell sorter. 
T-cell activation 
Proliferation assays. Mononuclear cells and 
thymocytes (1 X lo5 cells/well) were cultured in trip- 
licate in round-bottom 96-well plates in RPMI 
1640 (Bio Whittaker) supplemented with 10% FCS 
(Gibco), 2 mM glutamine and penicillin (100 
U/ml)/streptomycin (100 U/ml) at a total volume 
of 0.2 ml/well. Cells were stimulated with PHA, 
PMA, IL-2, anti-CD2, anti-CD3, and anti-CD98. 
At day 4 of culture, wells were pulsed overnight 
with tritiated thymidine (0.8 pCi/well) and har- 
vested, and thymidine incorporation was meas- 
ured. 
Kinetics of 806 expression. Peripheral blood 
mononuclear cells were cultured in RPMI supple- 
mented with 10% FCS, glutamine, and penicillin/ 
streptomycin at 1 X lo6 celldm1 alone or with vari- 
ous mitogens including PMA (1 ng/ml), PHA (0.5 
pg/ml), ionomycin (0.5 pg/ml), or a combination 
of PMA and ionomycin for 4 days at 37°C. On 
days 2 and 4, a subset of cells under each condition 
were stained with 8D6 and several other antibodies 
including OKT3, anti-Tac (anti-CD25/IL-2R), 7F8 
(anti-CD98). 
Apoptosis experiments 
Peripheral blood mononuclear cells were stimu- 
lated with PHA and then maintained in IL-2-con- 
taining medium as described above. Every 3-4 
days, a subset of the blasts were subcultured in me- 
dium alone, or supplemented with 8D6 antibody 
(1500) (or other agents with potential effects on 
apoptosis) for 24 h. Cells were fixed in 1% form- 
aldehyde for 15 min at 04°C and then rinsed in 
PBS. One million cells were resuspended in 50 p1 
of cacodylate buffer [0.2 M potassium cacodylate, 
25 mM Tris-HC1 (PH 6.6), 2.5 mM cobalt chloride, 
0.25 mg/ml bovine serum albumin, 100 pl/ml ter- 
minal deoxynucleotidyl transferase, 0.5 mM bi- 
otin-16 dUTP] and incubated for 30 min at 37°C. 
Cells were rinsed in PBS and resuspended in 100 
pl of saline-citrate buffer [2.5 pg/ml fluoresceinated 
avidin, 0.1% Triton X-100, 5% (w/v) non-fat dry 
milk, 0.6 M NaCl and 0.06 M sodium citrate] and 
incubated for 30 min at room temperature in the 
dark. Cells were rinsed in PBS containing 0.1% 
Triton X-100 and resuspended in 1 ml of PI buffer 
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Figure 1. Structures recognized by the novel monoclonal anti- 
body 8D6. Cells of the HSB-:! T cell line were metabolically 
labeled with [35]-S-methionine, lysed, precleared, immuno- 
precipitated, and analyzed by SDS-PAGE. Lanes 1-3, non-re- 
duced; lanes 4-6 reduced. Lanes 1 and 4. control murine IgGl 
monoclonal antibody. Lanes 2 and 5 ,  monoclonal antibody 
7F8, which recognizes the CD98 heterodimer. Lanes 3 and 6. 
monoclonal antibody 8D6. which recognizes a structure at -35 
kDa nonreduced and -40 kDa reduced. 
(PBS, 5 pg/ml PI, 0.1% RNAse A). Staining was 
analyzed by two-color flow cytometry. 
Results 
Characterization of structures recognized by the novel 
monoclonal antibody 8D6 
The 8D6 antibody recognizes an antigen on HSB-2 
cells of approximately 35 kDa under non-reducing 
conditions and approximately 40 kDa under re- 
ducing conditions, suggesting the presence of an 
intrachain disulfide bond (Figure 1). By comparing 
this biochemical data and the pattern of expression 
of the 8D6 antigen with known antigens from the 
Fifth International Leukocyte Workshop, the 8D6 
antigen appeared to be a novel cell surface struc- 
ture, not defined by CD classifications of the Fifth 
Workshop. Subsequently, in studies performed by 
the Sixth Workshop, 8D6 was found to identify 
CD147/neurothelin in binding assays both to 
transfectants and to beads coated with a CD147- 
Rg fusion protein (4). 
' 
8D6/neurothelin is expressed on a variety of cell types and 
is expressed more strongly on differentiated thymocytes than 
on mature T cells 
The 8D6 antibody binds to resting and activated 
peripheral blood mononuclear cells, thymocytes 
and transformed cell lines of both T-cell and non- 
T-cell origin. T-cell-derived populations that ex- 
press 8D6 include Jurkat, HSB2, Peer, Molt 4 and 
Molt 13. Other cells that bind 8D6 include UM- 
Mel-1, a melanoma line, and HepG2, a hepatoma 
line. This antigen is also expressed on synovial T 
cells and synoviocytes. 
Three-color flow cytometry analysis was per- 
formed to more precisely compare expression of 
CD 147/neurothelin on thymocytes and peripheral 
blood T cells (Figure 2). The use of monoclonal 
antibodies to CD3 and CD4 or CD3 and CD8 per- 
mitted selection of high CD3 (CD4+CD8-or 
CD4-'CD8+), mature thymocytes, with CD3 den- 
sity comparable to peripheral blood T lympho- 
cytes. This approach also permitted comparison of 
expression of 8D6/neurothelin on the CD4 and 
CD8 subsets. The results shown in Table 1 indicate 











Figure 2. Three-color analysis of monoclonal antibody 8D6 re- 
activity with CD4+ thymocytes and T cells. Histograms of 
thymocytes and peripheral blood mononuclear cells stained di- 
rectly with tricolor-conjugated anti-CD3 and phycoerythrin- 
conjugated anti-CD4, and indirectly with monoclonal antibody 
8D6. Left. Two-color histograms that identify the CD3+CD4+ 
subset in quadrant 2. The tricolor (CD3) background cursor is 
set to exclude low CD3' (stage 11) thymocytes. Right. Single- 
color histogriims of 8D6 fluorescence gated on cells in quad- 
runts 3 of adjacent panels. 
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Table 1. 
Relative binding of antibodies to thyrnocyte and peripheral blood T-cell sub- 
sets 
Percentage Net mean fluorescence 
Antibody Cell type positive (background subtracted) 
8D6 CD3hi,CD4+ thyrnocyte 99.4 15.515 
8D6 CD3+,CD4+ PBMC 89.7 4.214 
8D6 CD3hi,CD8+ thynocyte 99.6 13.176 
8D6 CD3+,CD8+ PBMC 95.1 4.46 
CD98 CD3hi,CD4+ thymocyte 53.4 2.355 
CD98 CD3+,CD4+ PBMC 16.4 0.884 
CD98 CD3hi,CD8+ thymocyte 63.0 2.81 6 
CD98 CD3+,CD8+ PBMC 50.6 1.52 
Net mean fluorescence intensity (in arbitrary units) was calculated from 
single-color fluorescence histograms of GO147 (8D6) and CD98 staining, 
gated on thyrnocyte and peripheral blood T-cell subsets, as in Figure 2. 
higher expression of both CD 147/neurothelin anti- 
gen and the CD98 antigen (formerly termed the 
4F2 antigen) than peripheral blood T lympho- 
cytes. This is most apparent when comparing the 
net mean fluorescence (Table 1). This suggests that 
the expression of this antigen is developmentally 
regulated, decreasing as thymocytes mature to be- 
come peripheral blood T cells. 
Expression of 8DG/neurothelin during short-term activation 
Peripheral blood mononuclear cells in short-term 
culture augment IL-2 receptor expression in the 
presence of various mitogens, including PHA, 
PMA ionomycin or a combination of ionomycin 
and PMA. In contrast, expression of 8D6heuro- 
thelin decreases slightly by day 4, as judged by net 
mean fluorescence (Figure 3). Similar results were 
obtained in the “blind panel” analysis conducted 
by the Sixth Leukocyte Differentiation Antigen 
Workshop (7). In  studies using T-cell lines main- 
tained in medium containing IL-2, expression of 
CD147 was found to gradually increase after day 
5 of culture, and high expression is found on long- 
term activated cells (data not shown). 
Functional assays 
The effects of 8D6 on thymocytes and peripheral 
blood mononuclear cells were examined by cocul- 
turing cells with PHA. PMA, IL-2, anti-CD2, anti- 
CD3 and anti-CD28. No consistent inhibitory or 
costimulatory effects of the 8D6 antibody on T-cell 
or thymocyte proliferation under these conditions 
were found (data not shown). 8D6 did not appear 
to affect apoptosis in cultured thymocytes (data 
not shown). 
Comparison with AD2 
The monoclonal antibody AD2 has been reported 
to recognize an antigen of similar molecular weight 
to the molecule immunoprecipitated by antibody 
8D6 (7). The binding of 8D6 and AD2 to various 
cell types was compared. 8D6 and AD2 both bind 
at high density to the T-cell lymphoma line, Jurkat 
(99.7% and 99.5%, respectively). However, AD2 
bound to the T-cell lymphoma lines HSB-2 and 
Hut78 at much lower density than 8D6. Studies 
performed during the Sixth Workshop clustered 
AD2 to a different novel antigen termed CD165 
(7). 
Discussion 
Reactivity of the novel monoclonal antibody 8D6 
with CD147/neurothelin has been established by 
binding to purified soluble protein, specific binding 
to transfectants, and dendrogram clustering in the 
Sixth Leukocyte Differentiation Antigen Work- 
shop analysis. Immunoprecipitation of radio- 
labeled HSB-2 cells reveals a single band, which 
increases slightly in apparent molecular weight 
upon reduction, consistent with the intrachain di- 
sulfide bonds in the immunoglobulin-like regions 
of CD147. CD147/neurothelin is a highly glycosyl- 
ated protein with a polypeptide core of 27.4 kDa. 
The apparent molecular weight of immunoprecip- 
itated material from different cell sources varies, 
with sizes ranging from 35 to 60 kDa. It is likely 
that the antigen expressed on HSB-2 cells is some- 
what less glycosylated than on other cell popula- 
tions, given the relatively lower molecular weight 
and the relatively narrow band resolved by SDS- 
PAGE. In contrast, immunoprecipitation of biotin 
labeled protein from Jurkat cells yielded a broad 
band in the range of 50-60 kDa with a slight ap- 
parent shift to a higher molecular mass upon re- 
duction (data not shown). 
During the course of these studies, a mono- 
clonal antibody termed AD2 was described with 
similar biochemical characteristics (8). However, 
cross-blocking studies and comparison of flow 
cytometric patterns on various cell lines indicated 
that AD2 did not recognize the same antigen as 
8D6. Subsequently, the workshop analysis has 
clustered AD2 to a distinct novel CD designation, 
CD165 (7). 
CD 147/neurothelin, although described initially 
as a tumor cell antigen and as a component of the 
blood-brain barrier, is expressed widely on 
hematopoietic cells. with high expression on all cell 
lines examined. The data in this report demon- 
strate a particiildy interesting pattern of ex- 
p ressi o n on h ii  m i  n T- 1 i lieage cel Is, w i t h high- i n ten- 
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Figure 3. Expression of 8D6/neurothelin during 
lymphocyte cultures, as analyzed by flow cyto- 
metry A. Net percentage of cells positive for 
8D6 (upper 5 lines and symbols) or CD25/IL- 
2R (lower five lines and symbols). B. Mean 
channel fluorescence (MCF) for 8D6/neurothel- 
in, expressed in arbitrary units. 
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sity expression on thymocytes and somewhat lower 
levels of expression on mature peripheral blood T 
cells. When mature single-positive CD4+ or CD8' 
thymocytes were compared with the corresponding 
peripheral blood T-cell subset, three-fold or greater 
differences in antigen density were noted. A simi- 
lar, although less striking, difference in antigen 
density was noted for CD98. Other T-cell differen- 
tiation antigens, such as CD3 and CD6, are ex- 
pressed less strongly on thymocytes than on ma- 
ture T cells. It is not known yet whether cord blood 
T cells resemble thymocytes or resemble T lympho- 
cytes from adult peripheral blood in terms of ex- 
pression of CD147 and CD98. Although ex- 
pression of CD147 is strong on long-term acti- 
vated T cells and T-cell lines, it does not appear to 
be induced early in the course of T-cell activation 
in a manner comparable to the CD25 subunit of' 
the IL-2 receptor or the CD98 antigen. 
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The regulated expression of CD147 during T-cell 
differentiation strongly suggests a function or 
functions for this molecule that may be specific to 
particular points in T-cell development. Studies 
thus far using the 8D6 monoclonal antibody have 
not yielded information as to the precise nature of 
the role of this structure in T-cell biology. Thus, 
8D6 was neither mitogenic nor comitogenic for T 
cells and failed to inhibit T-cell proliferative re- 
sponses. Furthermore, it did not induce or prevent 
apoptosis of cultured human thymocytes. It has 
been speculated that CD147 may mediate adhesive 
function in certain cells, although no data to sup- 
port this are yet available for lymphocytes. Desig- 
nation of neurothelin to a new specific CD cluster 
and definition of a variety of monoclonal anti- 
bodies reactive with this molecule should now lead 
to progress in understanding its role during 
lymphocyte development and activation. 
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